Cargando…

Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism

Non-alcoholic fatty liver disease (NAFLD) and depression are common disorders and have bidirectional contributing relationships to metabolic syndrome. We aimed to determine whether a fasting serum signature of recent, self-reported depressive symptoms could be identified in a heterogeneous NAFLD coh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radford-Smith, Daniel E., Patel, Preya J., Irvine, Katharine M., Russell, Anthony, Siskind, Dan, Anthony, Daniel C., Powell, Elizabeth E., Probert, Fay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735618/ https://www.ncbi.nlm.nih.gov/pubmed/34990473 http://dx.doi.org/10.1371/journal.pone.0261555

Ejemplares similares

Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease
por: Irvine, Katharine M., et al.
Publicado: (2021)

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
por: Patel, Preya J., et al.
Publicado: (2017)

Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests
por: Johnson, Amy L., et al.
Publicado: (2021)

The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017)

Modifying the maternal microbiota alters the gut–brain metabolome and prevents emotional dysfunction in the adult offspring of obese dams
por: Radford-Smith, Daniel E., et al.
Publicado: (2022)

HDL and LDL have distinct, opposing effects on LPS-induced brain inflammation
por: Radford-Smith, Daniel E., et al.
Publicado: (2023)

Post-inflammatory behavioural despair in male mice is associated with reduced cortical glutamate-glutamine ratios, and circulating lipid and energy metabolites
por: Chan, Shi Yu, et al.
Publicado: (2020)

Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation
por: Gadd, Victoria L., et al.
Publicado: (2016)

A multivariate blood metabolite algorithm stably predicts risk and resilience to major depressive disorder in the general population
por: Radford-Smith, Daniel E., et al.
Publicado: (2023)

Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes
por: Gracen, Lucy, et al.
Publicado: (2022)

High-density lipoproteins and non-alcoholic fatty liver disease
por: Hoekstra, Menno, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
por: Fon Tacer, Klementina, et al.
Publicado: (2011)

Lipid Rafts and Alzheimer’s Disease: Protein-Lipid Interactions and Perturbation of Signaling
por: Hicks, David A., et al.
Publicado: (2012)

A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At‐Risk Populations in Primary Care
por: Patel, PreyaJanubhai, et al.
Publicado: (2018)

Lipids and Lipoproteins in Health and Disease
por: Bezsonov, Evgeny E., et al.
Publicado: (2021)

Lipids, lipoprotein distribution and depressive symptoms: the Multi-Ethnic Study of Atherosclerosis
por: Ong, K L, et al.
Publicado: (2016)

Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis
por: Ahn, Sang Bong, et al.
Publicado: (2020)

Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial
por: Hayward, Kelly L., et al.
Publicado: (2017)

Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management
por: Patel, Preya Janubhai, et al.
Publicado: (2017)

T44. 12-MONTH FOLLOW UP OF METABOLIC MEASURES FOLLOWING A RANDOMISED CONTROLLED TRIAL OF TREATMENT OF CLOZAPINE ASSOCIATED OBESITY AND DIABETES WITH EXENATIDE (CODEX)
por: Siskind, Dan, et al.
Publicado: (2020)

Perturbation in kidney lipid metabolic profiles in diabetic rats with reference to alcoholic oxidative stress
por: Shanmugam, K. R., et al.
Publicado: (2009)

Lipids and Lipoproteins in Atherosclerosis
por: Chroni, Angeliki, et al.
Publicado: (2011)

Lipids and Lipoproteins in Atherosclerosis
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

Lipid droplet dynamics in alcoholic fatty liver disease
por: Schulze, Ryan J., et al.
Publicado: (2019)

A novel serum metabolomic panel distinguishes IgG4‐related sclerosing cholangitis from primary sclerosing cholangitis
por: Radford‐Smith, Daniel E., et al.
Publicado: (2022)

Perturbation of the Developmental Potential of Preimplantation Mouse Embryos by Hydroxyurea
por: Sampson, Mariam, et al.
Publicado: (2010)

Quantitative lipidomics reveals lipid perturbation in the liver of fatty liver hemorrhagic syndrome in laying hens
por: You, Manhua, et al.
Publicado: (2022)

Treatment of non-alcoholic fatty liver disease
por: Tolman, Keith G, et al.
Publicado: (2007)

Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis
por: Siskind, Dan J., et al.
Publicado: (2016)

Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease
por: Rao, Prahlad K., et al.
Publicado: (2018)

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
por: Pastori, Daniele, et al.
Publicado: (2018)

Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents
por: Chin, Justin, et al.
Publicado: (2020)

Human Lipoproteins at Model Cell Membranes: Effect of Lipoprotein Class on Lipid Exchange
por: Browning, K. L., et al.
Publicado: (2017)

Lipid and Lipoprotein Metabolism in Microglia
por: Loving, Bailey A., et al.
Publicado: (2020)

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
por: Chao, Hsu-Wen, et al.
Publicado: (2019)

Significance of Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio in Children with Non-Alcoholic Fatty Liver Disease
por: Kim, Hyun Jin
Publicado: (2023)

Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)
por: Mocciaro, Gabriele, et al.
Publicado: (2023)

Sex differences in lipid and lipoprotein metabolism
por: Palmisano, Brian T., et al.
Publicado: (2018)

Genetics of Lipid and Lipoprotein Disorders and Traits
por: Dron, Jacqueline S., et al.
Publicado: (2016)

Effects of aerobic exercise on lipids and lipoproteins
por: Wang, Yating, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lcu1l8aatdt5gfvrkdlmfup9h6